PH
At a glance
Registered since
2024
Senate LDA system
Clients
3
last 3 years
Filings
3
2 agencies contacted
Activity
filings by quarter
Works on
Specific issues
H.R. 4368 and S. 2131 (Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024), Title VI, regarding implementation of Modernization of Cosmetics Regulation Act (MOCRA) H.R. 4366 (Consolidated Appropriations Act, 2024), regarding implementation of Modernization of Cosmetics Regulation Act (MOCRA) Fiscal Year 2025 Food and Drug Administration appropriations, regarding implementation of Modernization of Cosmetics Regulation Act (MOCRA)
Implementation of Modernization of Cosmetics Regulation Act (MOCRA) regarding cosmetics ingredients and products
Implementation of P.L. 114-182 (Frank R. Lautenberg Chemical Safety for the 21st Century Act), regarding provisions related to the approval of new chemicals and risk evaluations
Policies related to corporate taxes and tax incentives, including research and experimentation expensing H.R. 7024 (Tax Relief for American Families and Workers Act of 2024), provisions related to corporate taxes and tax incentives, including research and experimentation expensing
H.R. 2940 and S. 1355 (PASTEUR Act of 2023), all provisions H.R. 4420 (Preparedness and Response Reauthorization Act), all provisions H.R. 4421 (Preparing for all Hazards and Pathogens Reauthorization Act), all provisions S. 2333 (Pandemic and All-Hazards Preparedness and Response Act), all provisions
H.R. 5894 and S. 2624 (Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2024), Title II, regarding funding for programs dealing with antimicrobial resistance and infectious diseases, including Bio-Preparedness Workforce Pilot Program H.R. 2882 (Further Consolidated Appropriations Act, 2024), Division D, Title II, regarding funding for programs dealing with antimicrobial resistance and infectious diseases, including Bio-Preparedness Workforce Pilot Program Fiscal Year 2025 funding for programs dealing with antimicrobial resistance and infectious diseases, including Bio-Preparedness Workforce Pilot Program